• Synairgen provides update on progress during 2023

  • Jun 27 2024
  • Duración: 3 m
  • Podcast

Synairgen provides update on progress during 2023 Por arte de portada

Synairgen provides update on progress during 2023

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Synairgen PLC chief executive Richard Marsden takes Proactive's Stephen Gunnion through the company's progress and future plans following the release of its full-year results. Marsden provided an overview of Synairgen's work over the past year, focusing on the development of an inhaled, broad-spectrum antiviral drug aimed at treating common respiratory viruses. He highlighted the exciting data generated from various clinical trials during the COVID-19 pandemic. Despite a decrease in hospitalisations due to current virus strains, the trials showed promising results in preventing severe outcomes in infected patients. Synairgen is now focusing on a Phase II trial for mechanically ventilated patients with severe viral lung infections. Marsden explained the rationale behind targeting this population, noting the high mortality rates and lack of antiviral therapeutic options for these patients. He also discussed the company's preparations for the trial, including lab work and collaborations with intensive care physicians. Marsden emphasised the strong commercial case for developing effective treatments in this area. Looking ahead, Synairgen is exploring funding options to support the upcoming trial, set to commence this winter. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #Synairgen #ClinicalTrials #RichardMarsden #AntiviralDrug #RespiratoryViruses #Phase2Trial #COVID19 #MedicalResearch #HealthcareInnovation #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Más Menos
activate_primeday_promo_in_buybox_DT
Empresas y Profesiones Economía Finanzas Personales Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre Synairgen provides update on progress during 2023

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles